IARC and WSI have organized and developed a new course on ‘Understanding Mutational Signatures of Cancer to Inform Prevention’, to take place at Wellcome Genome Campus in the United Kingdom on 15-18 ...
Proud to Be at ESMO 2026 with the Immunai Team / cancer, ESMO, esmo 2026, ESMO26, European Society for Medical Oncology, ...
Transforming Breast Cancer Care Through Collaboration and Innovation / Benjamin Ebert, BIDMC, Breast Cancer, Breast ...
Strengthening Breast Cancer Care Through Community Support and Leadership / Breast Cancer, cancer, Comprehensive Breast ...
The Test Was Done. Did the Patient Benefit? / Biomarker Access, biomarker testing, cancer genomics, clinical trial access, ...
Behind Every Advance in Radiotherapy Is a Team of Dedicated Medical Physicists / Anthony Walsh, cancer, Icon Group, Icon ...
Can Immune Biomarkers Predict Outcomes After Cemiplimab in cSCC? / cancer, cemiplimab, cutaneous squamous cell carcinoma, ...
Phase II Ivonescimab Study Reports 70.1% Major Pathological Response in Resectable NSCLC - Akeso Biopharma / Akeso, Akeso ...
Opinion
Michael Sapienza Joins Guardant Health’s High Table to Discuss the Future of Cancer Screening
Michael Sapienza Joins Guardant Health's High Table to Discuss the Future of Cancer Screening / cancer, Cancer Prevention, cancer screening, colorectal ...
Honored to Co-Chair LungO Virtual Lung Congress 2026 / cancer, Dobbie Pei-Hsing Chen, Estela Rodriguez, Lung cancer, LungÕ ...
FDA Approves J&J’s Dual-Targeted Therapy for Head and Neck Cancer / cancer, FDA, head and neck cancers, Joanna Sadowska, ...
Elizabeth Awo-Ejeh on Equity and Patient Advocacy / breastcancer, cancer, Elizabeth Awo-Ejeh, esmo 2026, ESMO26, Lived ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results